The Daily Independent column argues many assumed the Trump and Oz deal cut GLP-1 prices for everyone, but commercial, employer and most Medicaid plans were left out.
Recap by typeshit. Full story at Your Valley.
New generics and steady prices drove the jump in value despite fewer units sold, with Eli Lilly's tirzepatide featured in the breakdown.
A practical rundown of insurance coverage for Wegovy when it is prescribed for weight loss, aimed at people sorting out costs.
Medicare is rolling out a GLP-1 program priced at $50 a month. KTLA walks through who is eligible and who is left out.
Novo has lowered what it charges for Wegovy in China. Details on the size of the cut are in the full report.
29:58
Meg takes her weekly tirzepatide shot on camera and steps on the scale to share where her weight loss stands so far.
In Genome Medicine, diet-triggered delivery beat constant secretion on fat and liver fat, and kept down gut microbes carrying GLP-1-degrading peptidase genes.
Loading…